Home / Inspections / 1153966

FDA Inspection 1153966 — Medtronic Neuromodulation

Medtronic Neuromodulation — FEI 2182207

The FDA completed an inspection of Medtronic Neuromodulation on September 9, 2021 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 9, 2021
Fiscal Year
2021
Product Type
Devices
Project Area
Compliance: Devices
Location
Minneapolis, MN (United States)

Facility

Other inspections at this facility

  • 1206222 (VAI Fri May 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1187313 (VAI Thu Nov 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108789 (VAI Thu Oct 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102180 (NAI Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1059011 (NAI Thu Jun 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources